FINANCIALS

IGC Igc Pharma Inc 1326205

Income Statement
Revenue	igc20240930_10q	412,000
Net Income	igc20240930_10q	-1,717,000
Profit Margin		-416.75%

Balance Sheet
Current Assets	4,250,000
Assets	10,369,000
Current Liabilities	2,802,000
Liabilities	2,992,000
Equity	7,377,000
Shares Out	75,636,000

Cash Flow Statement
Operating Cash Flow	-2,748,000
Investing Cash Flow	-196,000

Market Analysis
Market Cap	26,208,154
Price	0.34
BVPS	0.10
PB	3.49
EPS	-0.21
PS	15.90
FCF	-2,944,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view IGC documents filed with the SEC.

IGC Filings Clear

View A List of Tickers